145 related articles for article (PubMed ID: 33883257)
21. CD8+ T cells regulate bone tumor burden independent of osteoclast resorption.
Zhang K; Kim S; Cremasco V; Hirbe AC; Collins L; Piwnica-Worms D; Novack DV; Weilbaecher K; Faccio R
Cancer Res; 2011 Jul; 71(14):4799-808. PubMed ID: 21602433
[TBL] [Abstract][Full Text] [Related]
22. USP47 deficiency in mice modulates tumor infiltrating immune cells and enhances antitumor immune responses in prostate cancer.
Wang QL; Lu SY; Xu DD; Ma JX; Guo R; Zhang L; Tang LY; Shen Y; Shen CL; Wang JJ; Wu YL; Lu LM; Wang ZG; Zhang HX
Cancer Immunol Immunother; 2024 Jun; 73(8):143. PubMed ID: 38832955
[TBL] [Abstract][Full Text] [Related]
23. Nociceptor neurons affect cancer immunosurveillance.
Balood M; Ahmadi M; Eichwald T; Ahmadi A; Majdoubi A; Roversi K; Roversi K; Lucido CT; Restaino AC; Huang S; Ji L; Huang KC; Semerena E; Thomas SC; Trevino AE; Merrison H; Parrin A; Doyle B; Vermeer DW; Spanos WC; Williamson CS; Seehus CR; Foster SL; Dai H; Shu CJ; Rangachari M; Thibodeau J; V Del Rincon S; Drapkin R; Rafei M; Ghasemlou N; Vermeer PD; Woolf CJ; Talbot S
Nature; 2022 Nov; 611(7935):405-412. PubMed ID: 36323780
[TBL] [Abstract][Full Text] [Related]
24. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8
Hu C; Qiao W; Li X; Ning ZK; Liu J; Dalangood S; Li H; Yu X; Zong Z; Wen Z; Gui J
Cell Metab; 2024 Mar; 36(3):630-647.e8. PubMed ID: 38309268
[TBL] [Abstract][Full Text] [Related]
25. Dysregulated Amino Acid Sensing Drives Colorectal Cancer Growth and Metabolic Reprogramming Leading to Chemoresistance.
Solanki S; Sanchez K; Ponnusamy V; Kota V; Bell HN; Cho CS; Kowalsky AH; Green M; Lee JH; Shah YM
Gastroenterology; 2023 Mar; 164(3):376-391.e13. PubMed ID: 36410445
[TBL] [Abstract][Full Text] [Related]
26. HSF1-Mediated Control of Cellular Energy Metabolism and mTORC1 Activation Drive Acute T-Cell Lymphoblastic Leukemia Progression.
Eroglu B; Pang J; Jin X; Xi C; Moskophidis D; Mivechi NF
Mol Cancer Res; 2020 Mar; 18(3):463-476. PubMed ID: 31744878
[TBL] [Abstract][Full Text] [Related]
27. NR4a1/2 deletion promotes accumulation of TCF1
Srirat T; Hayakawa T; Mise-Omata S; Nakagawara K; Ando M; Shichino S; Ito M; Yoshimura A
Cell Rep; 2024 Mar; 43(3):113898. PubMed ID: 38451819
[TBL] [Abstract][Full Text] [Related]
28. A retinoic acid--rich tumor microenvironment provides clonal survival cues for tumor-specific CD8(+) T cells.
Guo Y; Pino-Lagos K; Ahonen CA; Bennett KA; Wang J; Napoli JL; Blomhoff R; Sockanathan S; Chandraratna RA; Dmitrovsky E; Turk MJ; Noelle RJ
Cancer Res; 2012 Oct; 72(20):5230-9. PubMed ID: 22902413
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8
Drijvers JM; Gillis JE; Muijlwijk T; Nguyen TH; Gaudiano EF; Harris IS; LaFleur MW; Ringel AE; Yao CH; Kurmi K; Juneja VR; Trombley JD; Haigis MC; Sharpe AH
Cancer Immunol Res; 2021 Feb; 9(2):184-199. PubMed ID: 33277233
[TBL] [Abstract][Full Text] [Related]
30. Phospholipase D Mediates Glutamine-Induced mTORC1 Activation to Promote Porcine Intestinal Epithelial Cell Proliferation.
Zhu M; Lu EQ; Yan L; Liu G; Huang K; Xu E; Zhang YY; Li XG
J Nutr; 2024 Apr; 154(4):1119-1129. PubMed ID: 38365119
[TBL] [Abstract][Full Text] [Related]
31. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8
Cao T; Zhang W; Wang Q; Wang C; Ma W; Zhang C; Ge M; Tian M; Yu J; Jiao A; Wang L; Liu M; Wang P; Guo Z; Zhou Y; Chen S; Yin W; Yi J; Guo H; Han H; Zhang B; Wu K; Fan D; Wang X; Nie Y; Lu Y; Zhao X
Cell; 2024 Apr; 187(9):2288-2304.e27. PubMed ID: 38565142
[TBL] [Abstract][Full Text] [Related]
32. A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron.
Sharma G; Sharma A; Kim I; Cha DG; Kim S; Park ES; Noh JG; Lee J; Ku JH; Choi YH; Kong J; Lee H; Ko H; Lee J; Notaro A; Hong SH; Rhee JH; Kim SG; De Castro C; Molinaro A; Shin K; Kim S; Kim JK; Rudra D; Im SH
Nat Immunol; 2024 May; 25(5):790-801. PubMed ID: 38664585
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitness.
Tian H; Chai D; Wang G; Wang Q; Sun N; Jiang G; Li H; Song J; Fang L; Wang M; Guo Z; Zheng J
Cancer Immunol Immunother; 2023 Jul; 72(7):2151-2168. PubMed ID: 36828964
[TBL] [Abstract][Full Text] [Related]
34. Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation.
Wang YN; Lee HH; Jiang Z; Chan LC; Hortobagyi GN; Yu D; Hung MC
Int J Biol Sci; 2023; 19(10):2957-2973. PubMed ID: 37416781
[TBL] [Abstract][Full Text] [Related]
35. Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8
Ma S; Wu Q; Wu W; Tian Y; Zhang J; Chen C; Sheng X; Zhao F; Ding L; Wang T; Zhao L; Xie Y; Wang Y; Yue X; Wu Z; Wei J; Zhang K; Liang X; Gao L; Wang H; Wang G; Li C; Ma C
Adv Sci (Weinh); 2024 May; 11(18):e2310065. PubMed ID: 38447147
[TBL] [Abstract][Full Text] [Related]
36. 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages.
Xiao J; Wang S; Chen L; Ding X; Dang Y; Han M; Zheng Y; Shen H; Wu S; Wang M; Yang D; Li N; Dong C; Hu M; Su C; Li W; Hui L; Ye Y; Tang H; Wei B; Wang H
Immunity; 2024 May; 57(5):1087-1104.e7. PubMed ID: 38640930
[TBL] [Abstract][Full Text] [Related]
37. DEPDC5 protects CD8
Li S; Ouyang X; Sun H; Jin J; Chen Y; Li L; Wang Q; He Y; Wang J; Chen T; Zhong Q; Liang Y; Pierre P; Zou Q; Ye Y; Su B
Cell Discov; 2024 May; 10(1):53. PubMed ID: 38763950
[TBL] [Abstract][Full Text] [Related]
38. Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity.
Feng Q; Liu Z; Yu X; Huang T; Chen J; Wang J; Wilhelm J; Li S; Song J; Li W; Sun Z; Sumer BD; Li B; Fu YX; Gao J
Nat Commun; 2022 Sep; 13(1):4981. PubMed ID: 36068198
[TBL] [Abstract][Full Text] [Related]
39. Targeting metabolic circuitry to supercharge CD8
Cai Q; Tian Y; Shubhra QTH
Cell Metab; 2024 May; 36(5):884-886. PubMed ID: 38718753
[TBL] [Abstract][Full Text] [Related]
40. Fatostatin promotes anti-tumor immunity by reducing SREBP2 mediated cholesterol metabolism in tumor-infiltrating T lymphocytes.
Zhu L; Shi Y; Feng Z; Yuan D; Guo S; Wang Y; Shen H; Li Y; Yan F; Wang Y
Eur J Pharmacol; 2024 May; 971():176519. PubMed ID: 38522641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
